Standout Papers

Deacetylase inhibition promotes the generation and function of regulatory T cells 2007 2026 2013 2019 743
  1. Deacetylase inhibition promotes the generation and function of regulatory T cells (2007)
    Ran Tao, Edwin F. de Zoeten et al. Nature Medicine
  2. Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial (2020)
    Shukui Qin, Zhenggang Ren et al. The Lancet Oncology

Immediate Impact

22 by Nobel laureates 36 from Science/Nature 79 standout
Sub-graph 1 of 17

Citing Papers

Regulation and functions of non-m6A mRNA modifications
2023 Standout
Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy
2023 Standout
69 intermediate papers

Works of Chunxia Chen being referenced

Camrelizumab plus famitinib for advanced or metastatic urothelial carcinoma after platinum-based therapy: data from a multicohort phase 2 study
2022
A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains
2000
and 3 more

Author Peers

Author Last Decade Papers Cites
Chunxia Chen 2038 986 1289 176 4.9k
Nariyoshi Shinomiya 1970 876 898 192 4.9k
Peter Thomas 1697 1116 896 139 4.4k
Shinichi Kawai 1075 898 1304 180 6.3k
Kazuya Higashino 2335 563 1066 207 4.9k
Xiaoyan Cai 1428 712 777 133 5.0k
Bernard Weill 1540 623 1440 132 5.4k
Yutaka Kawahito 2058 771 907 175 6.0k
Carole Nicco 2125 594 1262 101 5.1k
Giuseppe Castello 1605 1304 910 132 4.4k
Koji Nakamura 2239 618 604 206 4.7k

All Works

Loading papers...

Rankless by CCL
2026